Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.19 USD
Change Today +0.09 / 1.27%
Volume 133.7K
GEN On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

genesis healthcare inc (GEN) Snapshot

Open
$7.09
Previous Close
$7.10
Day High
$7.33
Day Low
$7.08
52 Week High
02/3/15 - $9.32
52 Week Low
04/11/14 - $4.77
Market Cap
1.1B
Average Volume 10 Days
207.1K
EPS TTM
$0.26
Shares Outstanding
73.6M
EX-Date
--
P/E TM
27.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for GENESIS HEALTHCARE INC (GEN)

genesis healthcare inc (GEN) Related Bloomberg News

View More Bloomberg News

genesis healthcare inc (GEN) Related Businessweek News

No Related Businessweek News Found

genesis healthcare inc (GEN) Details

Genesis HealthCare, Inc., together with its subsidiaries, provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company offers sub-acute care, and rehabilitative and specialty healthcare skilled nursing care services; and room and board, and assistance with activities of daily living. It also provides rehabilitation therapy services, including physical therapy, occupational therapy, and/or speech language pathology services; hospice care and home health services; and private duty care services. As of March 24, 2015, the company owned or leased approximately 500 skilled nursing and assisted/senior living facilities in 34 states. Genesis Healthcare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

genesis healthcare inc (GEN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genesis healthcare inc (GEN) Key Developments

Genesis Healthcare, Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 10:15 AM

Genesis Healthcare, Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 10:15 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: George V. Hager, Chief Executive Officer and Director, Thomas DiVittorio, Chief Financial Officer, Treasurer and Assistant Secretary.

Genesis Healthcare, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Full Year Ending December 31, 2015

Genesis Healthcare, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the full year, the company announced its revenue and adjusted revenue was $4.77 billion and $4.75 billion, respectively, up from revenue and adjusted revenue of $4.71 billion and $4.69 billion, respectively, in the year ended December 31, 2013. Adjusted EBITDAR was $589.8 million and adjusted EBITDA was $140.6 million an increase of less than 1% from adjusted EBITDAR of $589.7 million and a decrease of 11.9% from adjusted EBITDA of $159.6 million in the prior year. The company’s loss from continuing operations for the year ended December 31, 2014 totaled $237.5 million, as compared to a loss from continuing operations of $169.6 million in the prior year. The company's adjusted income from continuing operations for the year ended December 31, 2014 totaled $24.7 million compared to adjusted income from continuing operations of $26.6 million in the prior year. For the year ended December 31, 2014, the company generated operating cash flow of $107.7 million. Total net debt at the date of the combination approximated $970 million. For the quarter, the company announced that its revenue and adjusted revenue was $1.19 billion, respectively, up from revenue and adjusted revenue of $1.19 and $1.18 billion, respectively, in the comparable period of the prior year. For the quarter ended December 31, 2014, the company's adjusted EBITDAR was $125.7 million and adjusted EBITDA was $12.0 million, a decrease of 15.4% from adjusted EBITDAR of $148.5 million and a decrease of 70.2% from adjusted EBITDA of $40.4 million in the comparable period in the prior year. The company’s loss from continuing operations for the quarter ended December 31, 2014 totaled $123.2 million, as compared to a loss from continuing operations of $54.2 million in the comparable period in the prior year. The company’s adjusted loss from continuing operations for the quarter ended December 31, 2014 totaled $2.3 million compared to adjusted income from continuing operations of $2.8 million in the same period in the prior year. The company provided earnings guidance for the full year ending December 31, 2015. The company expects adjusted EBITDAR of $755.0 million to $770.0 million and adjusted EBITDA of $267.6 million to $282.6 million. Recurring free cash flow in 2015 is projected to approximate $70.0 million after accounting for projected cash interest of $72.0 million, recurring capital expenditures of $76.0 million and cash taxes of $56.0 million. Cash income taxes assume tax depreciation and amortization expense approximating $62.0 million and a tax rate of 40.0%. The company announced that the low end range guidance for the fiscal 2015 is: to report GAAP net revenue to be $5,744,197,000, non-GAAP revenue to be $5,718,438,000, GAAP interest expense to be $507,203,000, non-GAAP interest expense to be $85,952,000, GAAP loss before income tax expense to be $87,011,000, non-GAAP income before income tax expense to be $86,357,000, GAAP loss from continuing operations to be $68,079,000, non-GAAP income from continuing operations to be $67,567,000, GAAP net loss attributable to the company to be $28,398,000 or $0.34 per diluted share, non-GAAP net income attributable to the company to be $28,185,000 or $0.34 per diluted share. EBITDAR expected to be $752,900,000 and EBITDA to be $731,015,000. Depreciation and amortization expected to be $221,834,000 on GAAP basis and Non-GAAP basis to be $95,309,000. The company announced that the high end range guidance for the fiscal 2015 is: to report GAAP net revenue to be $5,824,197,000, non-GAAP revenue to be $5,798,438,000, GAAP interest expense to be $508,003,000, non-GAAP interest expense to be $86,752,000, GAAP loss before income tax expense to be $73,544,000, non-GAAP income before income tax expense to be $99,824,000, GAAP loss from continuing operations to be $57,542,000, non-GAAP income from continuing operations to be $78,104,000, GAAP net loss attributable to the company to be $24,003,000 or $0.29 per diluted share, non-GAAP net income attributable to the company to be $32,580,000 or $0.39 per diluted share. EBITDAR expected to be $767,887,000 and EBITDA to be $746,002,000. Depreciation and amortization expected to be $222,554,000 on GAAP basis and Non-GAAP basis to be $96,029,000.

Genesis Healthcare Mulls Acquisitions

Genesis Healthcare, Inc. (NYSE:GEN) intends to pursue acquisitions. "Our growth beyond 2015 is expected to be fueled by a combination of organic growth, continued expansion of our best in class rehabilitation therapy segment and selective acquisitions and facility development; with an emphasis on growing our short stay PowerBack Rehabilitation brand," stated Genesis Chief Executive Officer, George V. Hager, Jr.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEN:US $7.19 USD +0.09

GEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $37.65 USD +0.39
Kindred Healthcare Inc $24.33 USD +0.95
National HealthCare Corp $63.99 USD +0.03
Ensign Group Inc/The $47.41 USD +2.05
View Industry Companies
 

Industry Analysis

GEN

Industry Average

Valuation GEN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENESIS HEALTHCARE INC, please visit www.genesishcc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.